Literature DB >> 9445015

Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells.

K J Rager1, J O Langland, B L Jacobs, D Proud, D G Marsh, F Imani.   

Abstract

An epidemiologic association between viral infections and the onset of asthma and allergy has been documented. Also, evidence from animal and human studies has suggested an increase in antigen-specific immunoglobulin E (IgE) production during viral infections, and elevated levels of IgE are characteristic of human asthma and allergy. Here, we provide molecular evidence for the roles of viral infection and of activation of the antiviral protein kinase (PKR) (double-stranded-RNA [dsRNA]-activated protein kinase) in the induction of IgE class switching. The presence of dsRNA, a known component of viral infection and an activator of PKR, induced IgE class switching as detected by the expression of germ line epsilon in the human Ramos B-cell line. Furthermore, dsRNA treatment of Ramos cells resulted in the activation of PKR and in vivo activation of the NF-kappaB complex. Interestingly, infection of Ramos cells with rhinovirus (common cold virus) serotypes 14 and 16 resulted in the induction of germ line epsilon expression. To further evaluate the role of PKR in the viral induction of IgE class switching, we infected Ramos cells with two different vaccinia virus (cowpox virus) strains. Infection with wild-type vaccinia virus failed to induce germ line epsilon expression; however, a deletion mutant of vaccinia virus (VP1080) lacking the PKR-inhibitory polypeptide E3L induced the expression of germ line epsilon. Collectively, the results of our study define a common molecular mechanism underlying the role of viral infections in IgE class switching and subsequent induction of IgE-mediated disorders such as allergy and asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445015      PMCID: PMC124593     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Antibody class switching.

Authors:  J Stavnezer
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

2.  Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein.

Authors:  F Imani; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Studies on the mechanisms of hypersensitivity phenomena. XIV. Passive sensitization in vitro of human leukocytes to ragweed pollen antigen.

Authors:  D A Levy; A G Osler
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

4.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

5.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor.

Authors:  Y Lu; M Wambach; M G Katze; R M Krug
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

6.  Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat.

Authors:  H Lebrec; K Sarlo; G R Burleson
Journal:  J Toxicol Environ Health       Date:  1996-12-27

7.  The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR.

Authors:  S R Brand; R Kobayashi; M B Mathews
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

8.  Differential transcriptional activation in vitro by NF-kappa B/Rel proteins.

Authors:  R Lin; D Gewert; J Hiscott
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

Authors:  E Beattie; K L Denzler; J Tartaglia; M E Perkus; E Paoletti; B L Jacobs
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  12 in total

Review 1.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

2.  Protein kinase R is a novel mediator of CD40 signaling and plays a critical role in modulating immunoglobulin expression during respiratory syncytial virus infection.

Authors:  Sheetal A Thakur; Zachary B Zalinger; Teresa R Johnson; Farhad Imani
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

Review 3.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 4.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

Review 5.  Immune pathways for translating viral infection into chronic airway disease.

Authors:  Michael J Holtzman; Derek E Byers; Loralyn A Benoit; John T Battaile; Yingjian You; Eugene Agapov; Chaeho Park; Mitchell H Grayson; Edy Y Kim; Anand C Patel
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

6.  EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.

Authors:  Bing He; Nancy Raab-Traub; Paolo Casali; Andrea Cerutti
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

7.  Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection.

Authors:  Radiah A Corn Minor; Gino V Limmon; Laura Miller-DeGraff; Darlene Dixon; Danica M K Andrews; Randal J Kaufman; Farhad Imani
Journal:  J Interferon Cytokine Res       Date:  2010-04       Impact factor: 2.607

Review 8.  New immune pathways from chronic post-viral lung disease.

Authors:  Loralyn A Benoit; Michael J Holtzman
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

9.  Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia.

Authors:  Mitchell H Grayson; Dorothy Cheung; Michelle M Rohlfing; Robert Kitchens; Daniel E Spiegel; Jennifer Tucker; John T Battaile; Yael Alevy; Le Yan; Eugene Agapov; Edy Y Kim; Michael J Holtzman
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.